Effect of a very late antigen‐4 receptor antagonist on allergen‐induced airway responses and inflammation in asthma

@article{Diamant2005EffectOA,
  title={Effect of a very late antigen‐4 receptor antagonist on allergen‐induced airway responses and inflammation in asthma},
  author={Z. Diamant and J. Kuperus and R. Baan and K. Nietzmann and S. Millet and P. Mendes and B. Miller and D. Amin and S. Rohatagi and P. Sterk and H. Hoogsteden and J. Prins},
  journal={Clinical \& Experimental Allergy},
  year={2005},
  volume={35}
}
Background Very late antigen‐4 (VLA4) plays a key role in the recruitment of eosinophils in allergic responses in animal studies. 
Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma.
Strategies for targeting T-cells in allergic diseases and asthma.
Very late antigen-4 integrin antagonists
A critical appraisal of methods used in early clinical development of novel drugs for the treatment of asthma.
Inhaled allergen bronchoprovocation tests.
The rabbit as a model to study asthma and other lung diseases.
...
1
2
3
...

References

SHOWING 1-10 OF 30 REFERENCES
Mechanisms regulating eosinophil extravasation in asthma.
  • E. Knol, D. Roos
  • Medicine
  • The European respiratory journal. Supplement
  • 1996
Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents.
A small molecule very late antigen-4 antagonist can inhibit ovalbumin-induced lung inflammation.
Reproducibility of allergen-induced early and late asthmatic responses.
Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation.
Alpha 4 integrin antagonists.
  • D. Jackson
  • Biology, Medicine
  • Current pharmaceutical design
  • 2002
...
1
2
3
...